Provided by Tiger Fintech (Singapore) Pte. Ltd.

GeneDx Holdings

130.66
+1.791.39%
Post-market: 137.506.84+5.23%19:47 EDT
Volume:867.49K
Turnover:113.17M
Market Cap:3.75B
PE:2.70K
High:133.72
Open:129.20
Low:126.44
Close:128.87
52wk High:136.00
52wk Low:55.17
Shares:28.73M
Float Shares:19.94M
Volume Ratio:2.15
T/O Rate:4.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0485
EPS(LYR):-1.9444
ROE:0.60%
ROA:1.05%
PB:13.54
PE(LYR):-67.20

Loading ...

Company Profile

Company Name:
GeneDx Holdings
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
1000
Office Location:
North Tower,6th Floor,333 Ludlow Street,Stamford,Connecticut,United States
Zip Code:
06902
Fax:
201 421 2010
Introduction:
GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It also provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. is headquartered in Stamford, Connecticut.

Directors

Name
Position
Jason Ryan
Chairman of the Board
Katherine Stueland
Chief Executive Officer and Director
Eli D. Casdin
Director
Emily Leproust
Director
Joshua Ruch
Director
Keith Meister
Director
Richard C. Pfenniger
Director
Thomas Fuchs
Director

Shareholders

Name
Position
Katherine Stueland
Chief Executive Officer and Director
Bryan Dechairo
Chief Operating Officer
Kevin Feeley
Chief Financial Officer